Mild Cognitive Impairment (MCI) clinical trials in Texas
21 active Mild Cognitive Impairment (MCI) trials with a site in Texas. Describe your situation to see which ones look like a fit.
- IHT for Mild Cognitive Impairment
- Stem Cell Therapy for Early Alzheimer's Disease
- Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
- Enhancing Attention in Elderly Using a Brain-Computer-Interface
- NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- ACT for Individuals With MNCD and Their Care Partners
- Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
- Cognitive Screening Made Easy for PCPs - Administrative Supplement
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- δ in Dementia Clinical Trials
- Paper-Based and Smartphone-Based Memory Supports
- Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment
- Alzheimer's Disease Neuroimaging Initiative 4
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- Rapamycin - Effects on Alzheimer's and Cognitive Health
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.